📝 Executive Summary
Major U.S. indices retreated as rising crude oil prices and geopolitical tensions dampened investor sentiment. Despite the broader market decline, Qualcomm and Amazon shares rallied following a multi-billion-dollar AI chip supply agreement, while Amgen and Novartis tumbled on clinical trial concerns.